Evaluation of efficacy and safety of glucokinase activators—a systematic review and meta-analysis

Overview of attention for article published in Frontiers in endocrinology, May 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (60th percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

So far, Altmetric has seen 1 Wikipedia article.

Globalagliatin (SY-004) is a glucokinase activator developed by Yabao Pharmaceutical Group for type 2 diabetes.

This page shows the most recent Wikipedia articles that mention this research output.

Click here to find out how to access more activity.